Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02502799 · ClinicalTrials.gov registry record · Phase 3
Intervention for Teens With ADHD and Substance Use
A Phase 3 study, sponsored by Florida International University.
- Terminated
- Registry status
- Phase 3
- Development phase
- 158
- Enrollment target
NCT02502799 is a Phase 3 study that was terminated before completion, run by Florida International University. The registered enrollment target is 158 participants.
The verdict
NCT02502799, a Phase 3 study, was terminated before completion, sponsored by Florida International University.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 158 participants
- Enrollment target
Study Summary
Individuals with ADHD are at markedly high risk for increased substance use and Substance Use Disorder (SUD). Given the strong evidence for the negative trajectory of individuals with co-occurring ADHD and substance use initiation, the goal of this study is to conduct a controlled examination of a brief, early intervention (BEI) for substance modified for adolescents with ADHD. Importantly, this intervention will address individuals who are at risk for problems with substance use, but do not yet meet criteria for severe SUD. Although brief interventions have been found to be effective in other populations, their efficacy in an ADHD population with emerging risk for substance use problems remains uninvestigated. This study aims to understand why some adolescents with ADHD and elevated risk for SUD respond to (BEI) and others do not. The investigators will test whether situational and individual characteristics predict substance use development and response to treatment. Further, this study will assess which types of additional treatment are most effective for youth who do not respond to the initial BEI. It is hypothesized that rates of adolescent substance use will be lower among adolescents who participate in study treatments.
Interventions
- DRUG Methylphenidate
- BEHAVIORAL Brief Early Intervention
- BEHAVIORAL Parent Training with Adolescent Cognitive Behavioral Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 158 participants |
| Start Date | 2015-07 |
| Est. Completion | 2021-08 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02502799
The ClinicalTrials.gov registry entry for NCT02502799 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 158 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Florida International University, which has 89 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Methylphenidate is the first listed.
NCT02502799 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02502799 about?
NCT02502799 is a clinical study titled "Intervention for Teens With ADHD and Substance Use". Individuals with ADHD are at markedly high risk for increased substance use and Substance Use Disorder (SUD). Given the strong evidence for the negative trajectory of individuals with co-occurring ADHD and substance use initiation, the goal of this study is to conduct a controlled examination of a b...
What is the current status of trial NCT02502799?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 158 participants. The study started on 2015-07. Estimated completion is 2021-08.
What interventions are being tested in trial NCT02502799?
The interventions under investigation include: Methylphenidate (DRUG), Brief Early Intervention (BEHAVIORAL), Parent Training with Adolescent Cognitive Behavioral Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT02502799?
This trial is sponsored by Florida International University, which has 89 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.